Coverage: September 19–25, 2026, using online-first publication dates. This was a relatively quiet week. The rotator-cuff consensus is the most clinically useful publication; the two older-adult resistance-training trials offer useful programming refinements. Nothing is clearly practice-changing. 1. The 2026 ESSKA–ESA formal consensus on partial-thickness posterosuperior rotator cuff tears (Part 2): Treatment strategies, rehabilitation, return to sport and complications Knee Surgery, Sports Traumatology, Arthroscopy, September 21, 2026 Type: Formal multidisciplinary consensus Article and DOI Methods and findings: A 13-surgeon steering group developed 33 questions and statements from a standardized literature review. Twenty independent shoulder surgeons then completed three rating rounds. Thirty recommendations reached strong agreement: one supported by Grade A evidence, six by Grade B, ten by Grade C, and thirteen by Grade D. The strongest conclusions were: - Begin with nonsurgical management, generally for at least six months when clinically appropriate. - Individualize treatment around symptoms, tear morphology and tissue quality, activity level, and sport demands. - Address meaningful stiffness before surgery. - Trans-tendon repair carries more postoperative-stiffness risk than completing and repairing an articular-sided partial tear. - Trans-tendon and tear-completion repairs produced broadly similar return-to-sport rates; the latter may carry a slightly greater retear risk. - No operative technique is consistently superior across all presentations. Evidence strength: Moderate for the overall management framework; low for many specific recommendations. The consensus process was structured and independently rated, but 23 of 30 recommendations rested on Grade C or D evidence. The panel was also composed principally of surgeons. Practical implications: A partial-thickness tear on imaging is not, by itself, an indication for surgery. Rehabilitation should progressively restore shoulder capacity and sport-specific exposure while considering symptoms, function, confidence, and tissue characteristics. “Six months” is a general management window, not a requirement to continue an ineffective program unchanged.